Here is BC. Less pronounced than Ontario and Alberta. Note: a large spike of deaths (600) was removed for the week ending July 3rd, 2021 as these may have been heat-wave related (same week).
I stress the above only suggests correlation and not necessarily causation. Causation should be investigated as correlations are troubling. Death counts are provisional & subject to change. Other provinces don't have material deaths in this category. Full '17-21 death data:
This analysis was inspired by @Milhouse_Van_Ho's great work today analyzing the same StatsCan data on all-cause mortality by cause of death. Note the 2021 increase in "ill-defined and unspecified causes of death".
BRAVO IRVIN: "As I am against mania, always, I ask for the immediate resignation of one of its chief exponents in the leading province of the land. Dr. Moore must resign. And the mania must stop now."
Dr. Kieran Moore: It is time that you resign in disgrace.
JUST NOW
(1/3)
Toronto MoH @epdevilla on child/youth vax.
Post-vax myocarditis risk is downplayed/inadequately communicated!
She cites population rate of 24.2 per 1m (PHO data), but does not clearly indicate the rate for 12-17 males is 5.5x higher (133.5/m) post 2-dose Pfizer!
JUST NOW
(2/3)
Listen closely: @epdevilla compares the all ages/sexes post-vax myo rate of 24.2 per 1m doses to the estimated 12-17yo post-C19 myo rate of 450 per 1m...
...without clearly stating the at least ~197 per 1m total risk for 12-17yo males post-vax reported by PHO!
JUST NOW
(3/3)
@epdevilla acknowledges myocarditis risk in males, but then downplays: cites NACI's "rare" characterization; "occurring in 0.01% to <0.1%" of vax recipients".
That is 1 in 1,000 to 1 in 10,000!
This is unacceptable risk; particularly for healthy young men!
Ontario Myocarditis Data Update
⏺️Large data dump w/45 new cases
⏺️Now 521 total cases
⏺️~1/2 in 12-29yo males
⏺️Pfizer: 12-17 yo's now 1 in ~5,000 & still📈
@PublicHealthON what's taken so long to report these cases? Dose levels low since summer, but reports still coming in!
Here you can see the week over week changes. Increases across many ages/sexes/doses. Young males continue to bear the brunt of this vaccination injury. Very sad.
Clip 1/3: My remarks at today’s @TorontoCouncil Board of Health meeting.
"Post-vaccine myocarditis risk increases as the age category decreases, and considering only 12 to 17-year-old males, the risk is closer to 1 in 5,000 males (from PHO). These boys are receiving Pfizer."
Clip 2/3:
"As a reminder, Pfizer’s global trials included less than 2,000 children [non-placebo] aged 12-17. Ontario’s young boys and men should not be treated as involuntary trial participants and deserve better protection from their [Ontario] Chief Medical Officer of Health."
Clip 3/3:
"In my line of work, if I miscalculate, misjudge, or inadequately balance risk and reward, I stand to lose only money. However, in public health, if miscalculations are made, members of the public can suffer real, unnecessary harm to their person."
Select highlights from Friday’s @TorontoCouncil meeting discussing Covid-19 response, w/important implications for Ontario at large.
Thank you @kristynwongtam for asking @epdevilla fair questions regarding myocarditis in young men and recent vaccine guidance changes:
2/6
In response to a question from the Speaker asking about differences between the vaccines, @epdevilla, insists they’re safe and effective, and does not publicly state the ~7-fold difference between Moderna and Pfizer in 18 to 24 males after their 2nd dose.👇🏼
3/6
@PublicHealthON, and by extension Toronto Public Health, were aware of this material difference in the Moderna/Pfizer safety profiles > 5 weeks ago. Did @epdevilla make the Board of Health or Councilors aware of this troubling difference in outcomes? What took so long?
12 to 17 Year Old Males
2nd dose myo risk is now just 1 in 8,500 doses
(avg of both Pfizer/Moderna)
This increasing rate is now approaching the 1 in 5,000 threshold cited in this week's Pfizer v Moderna change
Detail (1/3)👇
Detail (2/3)
Detail (3/3)
Chart showing the increasing rate of myocarditis in young males aged 12 - 17. Rate now approaching provinces cited incidence rate in 18 -24 yo males of 1 in 5,000 2nd Moderna doses.